Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis | MicrobiomeTrials← Back to trialsNCT04840056
Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis
RecruitingOBSERVATIONAL
Trial Details
Start: 2021-04-15Est. Completion: 2026-12-01
Enrollment target: 1,300 participants Locations- Prince of Wales Hospital, Shatin, New Territories, Hong Kong
Other microbiome trials you might be interested in
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinomaBile Duct CancerPancreas Cancer
Background:
\- Recent advances in cancer research have led to new therapies to treat the disease. It is important to co…
Bethesda, United StatesEst. completion Jun 30, 2035
Cystic FibrosisImmunologic Deficiency SyndromeTurner SyndromeCongenital Hepatic FibrosisIdiopathic Non-Cirrhotic Portal Hypertension
Background:
\- Noncirrhotic Portal Hypertension (NCPH) is caused by liver diseases that increase pressure in the blood …
Bethesda, United StatesEst. completion Sep 4, 2029
Non-GI CancersCancer of Gastrointestinal TractGastrointestinal Cancer
Background:
\- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Rese…
Bethesda, United States